Press Releases

Date	Press Release Title
June 10, 2008	Lifeline Biotechnologies, Inc. Prepares Patent Filing for Improved First Warning™ Diagnostic System
April 29, 2008	Lifeline Biotechnologies, Inc. CEO Reveals New Information in Audio Interview on Stockbully.com
April 23, 2008	Lifeline Biotechnologies, Inc. Featured on Stockbully.com
January 28, 2008	Lifeline Biotechnologies, Inc. Continues Merger and Acquisition Prospecting
January 2, 2008	Lifeline Biotechnologies, Inc. Expects to Upgrade Capabilities of Its First Warning System(TM) in 2008
December 17, 2007	Lifeline Biotechnologies, Inc. Analyzes Patient Data to Make First Warning System(TM) More User Friendly for Women
December 10, 2007	Lifeline Biotechnologies, Inc. Reviews Companies with Similar Products In Order to Proceed with FDA 510(k) Filing
December 5, 2007	Lifeline Biotechnologies, Inc.'s First Warning System(TM) in Preparation for Completion in 2008
November 26, 2007	Lifeline Biotechnologies, Inc. Receives Update on Development Status of First Warning System(TM)
November 20, 2007	Lifeline Biotechnologies, Inc. in Discussions with Firms to Begin Filing FDA 510(k) Submission for First Warning System™
November 13, 2007	Lifeline Biotechnologies, Inc. Expands Testing Worldwide to Improve First Warning System(TM)
November 7, 2007	Lifeline Biotechnologies, Inc. Prepares to Update Web site with Current Company Information
October 25, 2007	Lifeline Biotechnologies, Inc. Provides Patient Data for System Improvements
September 6, 2007	Lifeline Biotechnologies, Inc. Positioned for Continued Breast Cancer System Development and Advancement
August 1, 2007	Lifeline Biotechnologies, Inc. Announces New Trading Symbol
July 18, 2007	Lifeline Biotechnologies, Inc. Announces Capital Restructuring for Continued Growth and Potential Acquisitions
July 11, 2007	Lifeline Biotechnologies, Inc. Completes Exchange of Preferred Shares for Common Shares
July 9, 2007	Lifeline Biotechnologies, Inc. Finalizes Agreement For Development of Its First Warning System(TM)
June 14, 2007	Lifeline Biotechnologies, Inc. Extends Delivery Date for the Exchange of Common Stock for Preferred Stock